Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Circulation
Because ipamorelin has not completed human trials, its long-term safety is not established
In the first few weeks, you might start to notice a reduction in your appetite and changes in your eating habits
Is weight regain common after discontinuing retatrutide
The most frequent injuries involve long-term digestive problems, inflammation of the pancreas, gallbladder disease, kidney injury, and growing concerns about thyroid tumors
Some researchers find the larger injection volumes less comfortable, especially for daily protocols, though retatrutide is administered weekly which makes this less of a concern